JP2023539453A5 - - Google Patents
Info
- Publication number
- JP2023539453A5 JP2023539453A5 JP2023510435A JP2023510435A JP2023539453A5 JP 2023539453 A5 JP2023539453 A5 JP 2023539453A5 JP 2023510435 A JP2023510435 A JP 2023510435A JP 2023510435 A JP2023510435 A JP 2023510435A JP 2023539453 A5 JP2023539453 A5 JP 2023539453A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- variable domain
- single variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010842501 | 2020-08-20 | ||
| CN202010842501.X | 2020-08-20 | ||
| PCT/CN2021/112758 WO2022037528A1 (zh) | 2020-08-20 | 2021-08-16 | 结合bcma的单可变结构域及抗原结合分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539453A JP2023539453A (ja) | 2023-09-14 |
| JP2023539453A5 true JP2023539453A5 (https=) | 2024-08-26 |
| JP7821161B2 JP7821161B2 (ja) | 2026-02-26 |
Family
ID=80323414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023510435A Active JP7821161B2 (ja) | 2020-08-20 | 2021-08-16 | Ｂｃｍａと結合する単一可変ドメイン及び抗原結合分子 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230265181A1 (https=) |
| EP (1) | EP4201960A4 (https=) |
| JP (1) | JP7821161B2 (https=) |
| KR (1) | KR20230045095A (https=) |
| CN (1) | CN115698077A (https=) |
| WO (1) | WO2022037528A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022218380A1 (zh) * | 2021-04-15 | 2022-10-20 | 正大天晴药业集团股份有限公司 | 靶向bcma的多特异性抗体 |
| WO2025098446A1 (zh) * | 2023-11-07 | 2025-05-15 | 赛斯尔擎生物技术（上海）有限公司 | 抗bcma单域抗体及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX341884B (es) * | 2009-03-10 | 2016-09-07 | Biogen Ma Inc | Anticuerpos anti-antigeno de maduracion de celulas b (bcma). |
| UA112434C2 (uk) * | 2011-05-27 | 2016-09-12 | Ґлаксо Ґруп Лімітед | Антигензв'язувальний білок, який специфічно зв'язується з всма |
| WO2018028647A1 (en) | 2016-08-10 | 2018-02-15 | Legend Biotech Usa Inc. | Chimeric antigen receptors targeting bcma and methods of use thereof |
| CN105384825B (zh) * | 2015-08-11 | 2018-06-01 | 南京传奇生物科技有限公司 | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 |
| WO2018024237A1 (zh) * | 2016-08-04 | 2018-02-08 | 信达生物制药(苏州)有限公司 | 抗pd-l1纳米抗体及其应用 |
| WO2018068201A1 (en) * | 2016-10-11 | 2018-04-19 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies and variants thereof against ctla-4 |
| KR20250007003A (ko) * | 2017-06-20 | 2025-01-13 | 테네오바이오, 인코포레이티드 | 항-bcma 중쇄-단독 항체 |
| US11807663B2 (en) * | 2018-02-01 | 2023-11-07 | Innovent Biologics (Suzhou) Co., Ltd. | Fully humanized anti-B cell maturation antigen (BCMA) single-chain antibody and use thereof |
| CN109942708B (zh) * | 2019-03-28 | 2021-01-05 | 上海科棋药业科技有限公司 | 一种抗bcma的单域抗体及其应用 |
| CN109942709B (zh) * | 2019-04-22 | 2019-12-27 | 广州百暨基因科技有限公司 | 一种抗bcma的单域抗体及其应用 |
| WO2022218380A1 (zh) * | 2021-04-15 | 2022-10-20 | 正大天晴药业集团股份有限公司 | 靶向bcma的多特异性抗体 |
-
2021
- 2021-08-16 JP JP2023510435A patent/JP7821161B2/ja active Active
- 2021-08-16 US US18/020,584 patent/US20230265181A1/en active Pending
- 2021-08-16 CN CN202180041402.4A patent/CN115698077A/zh active Pending
- 2021-08-16 KR KR1020237008715A patent/KR20230045095A/ko active Pending
- 2021-08-16 EP EP21857623.9A patent/EP4201960A4/en active Pending
- 2021-08-16 WO PCT/CN2021/112758 patent/WO2022037528A1/zh not_active Ceased